Navigation Links
Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease

y's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.

Lipitor(R) (atorstatin calcium) is a registered trademark of Pfizer

Crestor(R) (rosuvastatin calcium) is a registered trademark of AstraZeneca

Zocor(R) (simvastatin) is a registered trademark of Merck & Co. Inc.

Contact

Corgenix Medical Corp.
William Critchfield, 303-453-8903
Senior VP and CFO
wcritchfield@corgenix.com
or
Investors:
The Investor Relations Group
Dian Griesel/ Erika Moran, 212-825-3210
Fax: 212-825-3229
or
Media:
Corgenix Medical Corp.
Chris Wolfe, 303-453-8856
Marketing Services Manager
cwolfe@corgenix.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
2. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
7. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
8. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
9. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
10. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
11. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
Post Your Comments:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Negative Pressure Wound Devices Draw FDA Notice, Advice 2DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 1BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 2BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 3BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 4BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 5BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 6BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 7BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 8BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 9BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 10BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 11BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 12BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 13BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 14BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results 60296 15House Judiciary Committee Hearing Calls Attention to Long Term Effects of Head Injury Among NFL Players 60291 1House Judiciary Committee Hearing Calls Attention to Long Term Effects of Head Injury Among NFL Players 60291 2Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 5806 1Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 5806 2